{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:09:56Z","timestamp":1791724196005,"version":"4.3.4"},"reference-count":151,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["NIDDK 069350"],"award-info":[{"award-number":["NIDDK 069350"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["032333"],"award-info":[{"award-number":["032333"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009210","name":"FDA","doi-asserted-by":"publisher","award":["002525"],"award-info":[{"award-number":["002525"]}],"id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shire\/Takeda Pharmaceuticals"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypoparathyroidism is a rare endocrine disorder characterized by hypocalcemia and low or undetectable levels of parathyroid hormone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This review is an evidence-based summary of hypoparathyroidism in terms of relevant pathophysiological, clinical, and therapeutic concepts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Many clinical manifestations of hypoparathyroidism are due to the lack of the physiological actions of parathyroid hormone on its 2 major target organs: the skeleton and the kidney. The skeleton is inactive, accruing bone without remodeling it. The kidneys lose the calcium-conserving actions of parathyroid hormone and, thus, excrete a greater fraction of calcium. Biochemical manifestations, besides hypocalcemia and low or undetectable levels of parathyroid hormone, include hyperphosphatemia and low levels of 1,25-dihydroxyvitamin D. Calcifications in the kidney, brain, and other soft tissues are common. Removal of, or damage to, the parathyroid glands at the time of anterior neck surgery is, by far, the most likely etiology. Autoimmune destruction of the parathyroid glands and other genetic causes represent most of the other etiologies. Conventional treatment with calcium and active vitamin D can maintain the serum calcium level but high doses may be required, adding to the risk of long-term soft tissue calcifications. The advent of replacement therapy with recombinant human PTH(1-84) represents a major step in the therapeutics of this disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Advances in our knowledge of hypoparathyroidism have led to greater understanding of the disease itself and our approach to it.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa113","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T19:26:16Z","timestamp":1587583576000},"page":"1722-1736","source":"Crossref","is-referenced-by-count":198,"title":["Hypoparathyroidism"],"prefix":"10.1210","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1570-2617","authenticated-orcid":false,"given":"John P","family":"Bilezikian","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"issue":"11","key":"2021122105020105700_CIT0001","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1210\/jc.2018-01225","article-title":"Primary hyperparathyroidism","volume":"103","author":"Bilezikian","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122105020105700_CIT0002"},{"key":"2021122105020105700_CIT0003"},{"issue":"6","key":"2021122105020105700_CIT0004","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1210\/jc.2015-3908","article-title":"Epidemiology and diagnosis of hypoparathyroidism","volume":"101","author":"Clarke","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122105020105700_CIT0005","doi-asserted-by":"crossref","first-page":"17080","DOI":"10.1038\/nrdp.2017.80","article-title":"Hypoparathyroidism","volume":"3","author":"Mannstadt","year":"2017","journal-title":"Nat Rev Dis Primers."},{"issue":"11","key":"2021122105020105700_CIT0006","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jcem.84.11.6236","article-title":"A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure","volume":"84","author":"John","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122105020105700_CIT0007","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/JME-16-0124","article-title":"Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis","volume":"57","author":"Hannan","year":"2016","journal-title":"J Mol Endocrinol."},{"key":"2021122105020105700_CIT0008","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr Opin Pharmacol."},{"key":"2021122105020105700_CIT0009","first-page":"1063","article-title":"Regulation of calcium homeostasis and genetic disorders that affect calcium metabolism.","volume-title":"Endocrinology","author":"Thakker","year":"2016","edition":"7"},{"key":"2021122105020105700_CIT0010","doi-asserted-by":"crossref","first-page":"f2213","DOI":"10.1136\/bmj.f2213","article-title":"Investigating hypocalcaemia","volume":"346","author":"Hannan","year":"2013","journal-title":"Bmj."},{"issue":"4","key":"2021122105020105700_CIT0011","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ecl.2018.07.006","article-title":"Medical hypoparathyroidism","volume":"47","author":"Siraj","year":"2018","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"3","key":"2021122105020105700_CIT0012","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF03350414","article-title":"Influence of magnesium on the secretion and action of parathyroid hormone","volume":"2","author":"Nair","year":"1979","journal-title":"J Endocrinol Invest."},{"issue":"3","key":"2021122105020105700_CIT0013","first-page":"113","article-title":"Magnesium as a regulatory cation: criteria and evaluation","volume":"6","author":"Grubbs","year":"1987","journal-title":"Magnesium."},{"issue":"18","key":"2021122105020105700_CIT0014","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMcp1800213","article-title":"Hypoparathyroidism","volume":"380","author":"Gafni","year":"2019","journal-title":"N Engl J Med."},{"issue":"4","key":"2021122105020105700_CIT0015","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ecl.2018.07.005","article-title":"Surgical hypoparathyroidism","volume":"47","author":"Kazaure","year":"2018","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"6","key":"2021122105020105700_CIT0016","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF03350718","article-title":"Late-onset hypocalcemia appearing years after thyroid surgery","volume":"12","author":"Halperin","year":"1989","journal-title":"J Endocrinol Invest."},{"issue":"7","key":"2021122105020105700_CIT0017","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1089\/thy.2017.0309","article-title":"American Thyroid Association statement on postoperative hypoparathyroidism: diagnosis, prevention, and management in adults","volume":"28","author":"Orloff","year":"2018","journal-title":"Thyroid."},{"issue":"4","key":"2021122105020105700_CIT0018","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/bjs.9676","article-title":"Importance of in situ preservation of parathyroid glands during total thyroidectomy","volume":"102","author":"Lorente-Poch","year":"2015","journal-title":"Br J Surg."},{"key":"2021122105020105700_CIT0019","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijsu.2016.08.019","article-title":"Predictors and risk factors of hypoparathyroidism after total thyroidectomy","volume":"34","author":"Cho","year":"2016","journal-title":"Int J Surg."},{"issue":"4","key":"2021122105020105700_CIT0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/bjs.9384","article-title":"Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia","volume":"101","author":"Edafe","year":"2014","journal-title":"Br J Surg."},{"issue":"4","key":"2021122105020105700_CIT0021","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ecl.2018.07.007","article-title":"Genetic disorders of parathyroid development and function","volume":"47","author":"Gordon","year":"2018","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"6","key":"2021122105020105700_CIT0022","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/cen.12944","article-title":"Diverse genetic aetiologies and clinical outcomes of paediatric hypoparathyroidism","volume":"83","author":"Kim","year":"2015","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"1","key":"2021122105020105700_CIT0023","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00125817-200101000-00005","article-title":"Endocrine aspects of the 22q11.2 deletion syndrome","volume":"3","author":"Weinzimer","year":"2001","journal-title":"Genet Med."},{"issue":"9596","key":"2021122105020105700_CIT0024","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(07)61601-8","article-title":"Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes","volume":"370","author":"Kobrynski","year":"2007","journal-title":"Lancet."},{"issue":"9393","key":"2021122105020105700_CIT0025","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0140-6736(03)14632-6","article-title":"Role of TBX1 in human del22q11.2 syndrome","volume":"362","author":"Yagi","year":"2003","journal-title":"Lancet."},{"issue":"3","key":"2021122105020105700_CIT0026","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1006\/bbrc.1999.0308","article-title":"Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla","volume":"257","author":"Heino","year":"1999","journal-title":"Biochem Biophys Res Commun."},{"issue":"2","key":"2021122105020105700_CIT0027","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.immuni.2005.07.005","article-title":"The cellular mechanism of Aire control of T cell tolerance","volume":"23","author":"Anderson","year":"2005","journal-title":"Immunity."},{"key":"2021122105020105700_CIT0028","doi-asserted-by":"crossref","first-page":"e88782","DOI":"10.1172\/jci.insight.88782","article-title":"Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"1","author":"Ferre","year":"2016","journal-title":"JCI Insight."},{"issue":"1","key":"2021122105020105700_CIT0029","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.autrev.2017.11.012","article-title":"The immunobiology and clinical features of type 1 autoimmune polyglandular syndrome (APS-1)","volume":"17","author":"Guo","year":"2018","journal-title":"Autoimmun Rev."},{"issue":"26","key":"2021122105020105700_CIT0030","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G\u2014protein \u03b1 subunit 11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N Eng J Med."},{"issue":"15","key":"2021122105020105700_CIT0031","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","article-title":"A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor","volume":"335","author":"Pearce","year":"1996","journal-title":"N Engl J Med."},{"issue":"3","key":"2021122105020105700_CIT0032","doi-asserted-by":"crossref","first-page":"F485","DOI":"10.1152\/ajprenal.00608.2009","article-title":"Physiology and pathophysiology of the calcium-sensing receptor in the kidney","volume":"298","author":"Riccardi","year":"2010","journal-title":"Am J Physiol Renal Physiol."},{"issue":"9","key":"2021122105020105700_CIT0033","doi-asserted-by":"crossref","first-page":"E1774","DOI":"10.1210\/jc.2014-1029","article-title":"Autosomal dominant hypoparathyroidism caused by germline mutation in GNA11: phenotypic and molecular characterization","volume":"99","author":"Li","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122105020105700_CIT0034","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/hmg\/ddl454","article-title":"Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor","volume":"16","author":"Ali","year":"2007","journal-title":"Hum Mol Genet."},{"issue":"15","key":"2021122105020105700_CIT0035","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJM199210083271506","article-title":"Brief report: autosomal dominant familial hypoparathyroidism, sensorineural deafness, and renal dysplasia","volume":"327","author":"Bilous","year":"1992","journal-title":"N Engl J Med."},{"issue":"1-2","key":"2021122105020105700_CIT0036","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","article-title":"MELAS syndrome: clinical manifestations, pathogenesis, and treatment options","volume":"116","author":"El-Hattab","year":"2015","journal-title":"Mol Genet Metab."},{"issue":"1","key":"2021122105020105700_CIT0037","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2265.1992.tb02289.x","article-title":"Endocrine dysfunction in Kearns-Sayre syndrome","volume":"37","author":"Harvey","year":"1992","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"5","key":"2021122105020105700_CIT0038","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/ajmg.a.36434","article-title":"Mutations in HADHB, which encodes the \u03b2-subunit of mitochondrial trifunctional protein, cause infantile onset hypoparathyroidism and peripheral polyneuropathy","volume":"164A","author":"Naiki","year":"2014","journal-title":"Am J Med Genet A."},{"key":"2021122105020105700_CIT0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13633-016-0041-7","article-title":"Short stature and hypoparathyroidism in a child with Kenny-Caffey syndrome type 2 due to a novel mutation in FAM111A gene","volume":"2017","author":"Abraham","year":"2017","journal-title":"Int J Pediatr Endocrinol."},{"issue":"10","key":"2021122105020105700_CIT0040","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/hmg\/ddq084","article-title":"Identification and characterization of novel parathyroid-specific transcription factor Glial Cells Missing Homolog B (GCMB) mutations in eight families with autosomal recessive hypoparathyroidism","volume":"19","author":"Bowl","year":"2010","journal-title":"Hum Mol Genet."},{"issue":"10","key":"2021122105020105700_CIT0041","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1172\/JCI24156","article-title":"An interstitial deletion-insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3, causes X-linked recessive hypoparathyroidism","volume":"115","author":"Bowl","year":"2005","journal-title":"J Clin Invest."},{"issue":"7","key":"2021122105020105700_CIT0042","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/ng.3304","article-title":"Factors influencing success of clinical genome sequencing across a broad spectrum of disorders","volume":"47","author":"Taylor","year":"2015","journal-title":"Nat Genet."},{"issue":"3","key":"2021122105020105700_CIT0043","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bone.2012.06.009","article-title":"A novel homozygous mutation in the parathyroid hormone gene (PTH) in a girl with isolated hypoparathyroidism","volume":"51","author":"Ertl","year":"2012","journal-title":"Bone."},{"issue":"2","key":"2021122105020105700_CIT0044","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ng0592-149","article-title":"A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism","volume":"1","author":"Parkinson","year":"1992","journal-title":"Nat Genet."},{"issue":"10","key":"2021122105020105700_CIT0045","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/jbmr.2532","article-title":"A homozygous [Cys25]PTH(1-84) mutation that impairs PTH\/PTHrP receptor activation defines a novel form of hypoparathyroidism","volume":"30","author":"Lee","year":"2015","journal-title":"J Bone Miner Res."},{"issue":"4","key":"2021122105020105700_CIT0046","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMcp0803050","article-title":"Clinical practice. Hypoparathyroidism","volume":"359","author":"Shoback","year":"2008","journal-title":"N Engl J Med."},{"issue":"9","key":"2021122105020105700_CIT0047","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J Bone Miner Res."},{"issue":"11","key":"2021122105020105700_CIT0048","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/jbmr.2273","article-title":"Postsurgical hypoparathyroidism\u2013risk of fractures, psychiatric diseases, cancer, cataract, and infections","volume":"29","author":"Underbjerg","year":"2014","journal-title":"J Bone Miner Res."},{"issue":"8","key":"2021122105020105700_CIT0049","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1210\/jc.2016-1477","article-title":"Epidemiology and health-related quality of life in hypoparathyroidism in Norway","volume":"101","author":"Astor","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122105020105700_CIT0050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00223-016-0222-7","article-title":"The epidemiology of hypoparathyroidism in Italy: an 8-year register-based study","volume":"100","author":"Cipriani","year":"2017","journal-title":"Calcif Tissue Int."},{"issue":"2","key":"2021122105020105700_CIT0051","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00223-018-0405-5","article-title":"Prevalence of chronic hypoparathyroidism in a Mediterranean region as estimated by the analysis of anonymous healthcare database","volume":"103","author":"Cianferotti","year":"2018","journal-title":"Calcif Tissue Int."},{"issue":"2","key":"2021122105020105700_CIT0052","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cen.13895","article-title":"Increased mortality and morbidity in patients with chronic hypoparathyroidism: a population-based study","volume":"90","author":"Vadiveloo","year":"2019","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"2021122105020105700_CIT0053","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00041552-200207000-00006","article-title":"Magnesium and the parathyroid","volume":"11","author":"Vetter","year":"2002","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"2","key":"2021122105020105700_CIT0054","doi-asserted-by":"crossref","DOI":"10.1177\/1759091415578050","article-title":"Hypocalcemia-induced seizure: demystifying the calcium paradox","volume":"7","author":"Han","year":"2015","journal-title":"ASN Neuro."},{"issue":"1","key":"2021122105020105700_CIT0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0002-9610(58)90868-7","article-title":"The Chvostek sign; a clinical study","volume":"96","author":"Hoffman","year":"1958","journal-title":"Am J Surg."},{"issue":"2","key":"2021122105020105700_CIT0056","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/archinte.1967.00300020074009","article-title":"Neurological manifestations of hypoparathyroidism","volume":"120","author":"Fonseca","year":"1967","journal-title":"Arch Intern Med."},{"issue":"22","key":"2021122105020105700_CIT0057","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM196606022742203","article-title":"Effect of diphenylhydantoin and phenobarbital on overt and latent tetany","volume":"274","author":"Schaaf","year":"1966","journal-title":"N Engl J Med."},{"issue":"12","key":"2021122105020105700_CIT0058","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122105020105700_CIT0059","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2013-3863","article-title":"Expression of osteogenic molecules in the caudate nucleus and gray matter and their potential relevance for Basal Ganglia calcification in hypoparathyroidism","volume":"99","author":"Goswami","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021122105020105700_CIT0060","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2265.2012.04353.x","article-title":"Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism","volume":"77","author":"Goswami","year":"2012","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2021122105020105700_CIT0061","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2169\/internalmedicine.35.129","article-title":"A rare case of idiopathic hypoparathyroidism with varied neurological manifestations","volume":"35","author":"Abe","year":"1996","journal-title":"Intern Med."},{"issue":"11","key":"2021122105020105700_CIT0062","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/BF00185605","article-title":"Reversible hyperkinesia in a patient with autoimmune polyglandular syndrome type I","volume":"71","author":"Baumert","year":"1993","journal-title":"Clin Investig."},{"issue":"6","key":"2021122105020105700_CIT0063","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1530\/EJE-12-0946","article-title":"Neuropsychological dysfunction in idiopathic hypoparathyroidism and its relationship with intracranial calcification and serum total calcium","volume":"168","author":"Aggarwal","year":"2013","journal-title":"Eur J Endocrinol."},{"issue":"4","key":"2021122105020105700_CIT0064","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ecl.2018.07.001","article-title":"Signs and symptoms of hypoparathyroidism","volume":"47","author":"Cusano","year":"2018","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"4","key":"2021122105020105700_CIT0065","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ecl.2018.07.009","article-title":"Hypoparathyroidism and the kidney","volume":"47","author":"Peacock","year":"2018","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"11","key":"2021122105020105700_CIT0066","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/jbmr.1979","article-title":"Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study","volume":"28","author":"Underbjerg","year":"2013","journal-title":"J Bone Miner Res."},{"issue":"4","key":"2021122105020105700_CIT0067","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ecl.2018.07.008","article-title":"Skeletal manifestations of hypoparathyroidism","volume":"47","author":"Rubin","year":"2018","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"11","key":"2021122105020105700_CIT0068","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/jbmr.452","article-title":"PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism","volume":"26","author":"Rubin","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2021122105020105700_CIT0069","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/8756-3282(95)00443-2","article-title":"Bone histomorphometry in hypoparathyroid patients treated with vitamin D","volume":"18","author":"Langdahl","year":"1996","journal-title":"Bone."},{"issue":"12","key":"2021122105020105700_CIT0070","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","article-title":"Dynamic and structural properties of the skeleton in hypoparathyroidism","volume":"23","author":"Rubin","year":"2008","journal-title":"J Bone Miner Res."},{"key":"2021122105020105700_CIT0071","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/B978-0-12-397166-1.00054-0","article-title":"Skeletal manifestations of hypoparathyroidism.","volume-title":"The Parathyroids","author":"Rubin","year":"2015","edition":"3"},{"issue":"1","key":"2021122105020105700_CIT0072","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bone.2009.09.020","article-title":"Three dimensional cancellous bone structure in hypoparathyroidism","volume":"46","author":"Rubin","year":"2010","journal-title":"Bone."},{"key":"2021122105020105700_CIT0073","first-page":"1135","article-title":"Indices of bone quality are markedly abnormal in hypoparathyroidism","volume":"Supp 21","author":"Rubin","year":"2006","journal-title":"J Bone Miner Res."},{"issue":"6","key":"2021122105020105700_CIT0074","first-page":"1617","article-title":"Bone mineral density in patients with chronic hypoparathyroidism","volume":"76","author":"Abugassa","year":"1993","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021122105020105700_CIT0075","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1172\/JCI110570","article-title":"Differential effects of endocrine dysfunction on the axial and the appendicular skeleton","volume":"69","author":"Seeman","year":"1982","journal-title":"J Clin Invest."},{"issue":"2","key":"2021122105020105700_CIT0076","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00000441-199508000-00003","article-title":"Hypoparathyroidism counteracts risk factors for osteoporosis","volume":"310","author":"Touliatos","year":"1995","journal-title":"Am J Med Sci."},{"issue":"7","key":"2021122105020105700_CIT0077","first-page":"2135","article-title":"Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism","volume":"80","author":"Fujiyama","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2021122105020105700_CIT0078","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jc.2003-030470","article-title":"Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects","volume":"88","author":"Chen","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021122105020105700_CIT0079","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/jbmr.2609","article-title":"Noninvasive assessment of skeletal microstructure and estimated bone strength in hypoparathyroidism","volume":"31","author":"Cusano","year":"2016","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2021122105020105700_CIT0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00198-009-0945-7","article-title":"Assessment of trabecular and cortical architecture and mechanical competence of bone by transilial bone biopsy: comparison with high-resolution peripheral computed tomography","volume":"21","author":"Cohen","year":"2010","journal-title":"Osteoporosis Int\u2019l."},{"issue":"1","key":"2021122105020105700_CIT0081","first-page":"251","article-title":"Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long-term follow-up","volume":"102","author":"Chawla","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021122105020105700_CIT0082","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1210\/jc.2015-3909","article-title":"Presentation of hypoparathyroidism: etiologies and clinical features","volume":"101","author":"Shoback","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021122105020105700_CIT0083","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/eje.0.1460215","article-title":"Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D","volume":"146","author":"Arlt","year":"2002","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2021122105020105700_CIT0084","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1210\/jc.2013-1239","article-title":"The effect of PTH(1-84) on quality of life in hypoparathyroidism","volume":"98","author":"Cusano","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2021122105020105700_CIT0085","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/jbmr.2812","article-title":"Concurrent hypoparathyroidism is associated with impaired physical function and quality of life in hypothyroidism","volume":"31","author":"Sikjaer","year":"2016","journal-title":"J Bone Miner Res."},{"issue":"5","key":"2021122105020105700_CIT0086","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4158\/EP13321.OR","article-title":"Surgeons and patients disagree on the potential consequences from hypoparathyroidism","volume":"20","author":"Cho","year":"2014","journal-title":"Endocr Pract."},{"issue":"4","key":"2021122105020105700_CIT0087","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ecl.2018.07.010","article-title":"Quality of life in hypoparathyroidism","volume":"47","author":"Vokes","year":"2018","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"2","key":"2021122105020105700_CIT0088","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1210\/jc.2017-01471","article-title":"Recombinant human parathyroid hormone effect on health-related quality of life in adults with chronic hypoparathyroidism","volume":"103","author":"Vokes","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021122105020105700_CIT0089","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/hrt.73.6.523","article-title":"Dynamic assessment of the electrocardiographic QT interval during citrate infusion in healthy volunteers","volume":"73","author":"Davis","year":"1995","journal-title":"Br Heart J."},{"issue":"2","key":"2021122105020105700_CIT0090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10741-013-9371-1","article-title":"Reversible cardiac dysfunction associated with hypocalcemia: a systematic review and meta-analysis of individual patient data","volume":"19","author":"Newman","year":"2014","journal-title":"Heart Fail Rev."},{"issue":"3","key":"2021122105020105700_CIT0091","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jbmr.3623","article-title":"Cardiovascular autonomic neuropathy as a new complication of postsurgical chronic hypoparathyroidism","volume":"34","author":"Tabacco","year":"2019","journal-title":"J Bone Miner Res."},{"issue":"4","key":"2021122105020105700_CIT0092","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00774-016-0767-6","article-title":"Long-term outcome of cataract surgery in patients with idiopathic hypoparathyroidism and its relationship with their calcemic status","volume":"35","author":"Saha","year":"2017","journal-title":"J Bone Miner Metab."},{"issue":"5","key":"2021122105020105700_CIT0093","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4103\/2230-8210.100637","article-title":"Mucocutaneous manifestations of acquired hypoparathyroidism: an observational study","volume":"16","author":"Sarkar","year":"2012","journal-title":"Indian J Endocrinol Metab."},{"issue":"3","key":"2021122105020105700_CIT0094","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2133.2005.06460.x","article-title":"Hypocalcaemia-induced pustular psoriasis-like skin eruption","volume":"152","author":"Lee","year":"2005","journal-title":"Br J Dermatol."},{"issue":"3","key":"2021122105020105700_CIT0095","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000442380","article-title":"A case of acute pustular psoriasis of von Zumbusch triggered by hypocalcemia","volume":"7","author":"Guerreiro de Moura","year":"2015","journal-title":"Case Rep Dermatol."},{"issue":"6","key":"2021122105020105700_CIT0096","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/jc.2015-3907","article-title":"Management of hypoparathyroidism: summary statement and guidelines","volume":"101","author":"Brandi","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021122105020105700_CIT0097","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ecl.2018.07.012","article-title":"Conventional treatment of hypoparathyroidism","volume":"47","author":"Babey","year":"2018","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"6","key":"2021122105020105700_CIT0098","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1210\/jc.2015-3910","article-title":"Management of hypoparathyroidism: present and future","volume":"101","author":"Bilezikian","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"(4)","key":"2021122105020105700_CIT0099","doi-asserted-by":"crossref","first-page":"e1215","DOI":"10.1210\/clinem\/dgz319","article-title":"Nephrocalcinosis, renal dysfunction and calculi in idiopathic hypoparathyroidism on long-term conventional therapy","volume":"105","author":"Saha","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2021122105020105700_CIT0100","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/ajcn\/49.2.372","article-title":"Meal effects on calcium absorption","volume":"49","author":"Heaney","year":"1989","journal-title":"Am J Clin Nutr."},{"issue":"1","key":"2021122105020105700_CIT0101","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1210\/jc.2012-2984","article-title":"Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety","volume":"98","author":"Cusano","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2021122105020105700_CIT0102","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/CIRCULATIONAHA.106.673491","article-title":"Calcium\/vitamin D supplementation and cardiovascular events","volume":"115","author":"Hsia","year":"2007","journal-title":"Circulation."},{"key":"2021122105020105700_CIT0103","doi-asserted-by":"crossref","first-page":"c3691","DOI":"10.1136\/bmj.c3691","article-title":"Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis","volume":"341","author":"Bolland","year":"2010","journal-title":"BMJ."},{"key":"2021122105020105700_CIT0104","doi-asserted-by":"crossref","first-page":"d2040","DOI":"10.1136\/bmj.d2040","article-title":"Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women\u2019s Health Initiative limited access dataset and meta-analysis","volume":"342","author":"Bolland","year":"2011","journal-title":"Bmj."},{"issue":"12","key":"2021122105020105700_CIT0105","doi-asserted-by":"crossref","first-page":"856","DOI":"10.7326\/M16-1165","article-title":"Calcium intake and cardiovascular disease risk: an updated systematic review and meta-analysis","volume":"165","author":"Chung","year":"2016","journal-title":"Ann Intern Med."},{"issue":"1","key":"2021122105020105700_CIT0106","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jbmr.176","article-title":"Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up","volume":"26","author":"Lewis","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"1","key":"2021122105020105700_CIT0107","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2021122105020105700_CIT0108","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1111\/bcp.13652","article-title":"Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D","volume":"84","author":"Sempos","year":"2018","journal-title":"Br J Clin Pharmacol."},{"issue":"5","key":"2021122105020105700_CIT0109","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1210\/jc.2016-3712","article-title":"Hypoparathyroidism: less severe hypocalcemia with treatment with vitamin D2 compared with calcitriol","volume":"102","author":"Streeten","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2021122105020105700_CIT0110","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1210\/jc.2019-00207","article-title":"Differential effects of oral boluses of vitamin D2 vs vitamin D3 on vitamin D metabolism: a randomized controlled trial","volume":"104","author":"Martineau","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"26","key":"2021122105020105700_CIT0111","doi-asserted-by":"crossref","first-page":"15455","DOI":"10.1074\/jbc.270.26.15455","article-title":"Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor","volume":"270","author":"Usdin","year":"1995","journal-title":"J Biol Chem."},{"key":"2021122105020105700_CIT0112","first-page":"540","article-title":"Evidence that parathyroid hormone crosses the blood-brain barrier.","volume-title":"Calcium Regulation and Bone Metabolism: Basic and Clinical Aspects: Proceedings of the 9th International Conference on Calcium Regulating Hormones and Bone Metabolism. Nice, France. October 25-November 1, 1986","author":"Care","year":"1987"},{"issue":"2","key":"2021122105020105700_CIT0113","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1172\/JCI100224","article-title":"Studies on the physiology of the parathyroid glands: I. Calcium and phosphorus studies on a case of idiopathic hypoparathyroidism","volume":"7","author":"Albright","year":"1929","journal-title":"J Clin Invest."},{"issue":"8","key":"2021122105020105700_CIT0114","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","article-title":"Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism","volume":"276","author":"Winer","year":"1996","journal-title":"JAMA."},{"issue":"10","key":"2021122105020105700_CIT0115","first-page":"3480","article-title":"A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism","volume":"83","author":"Winer","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2021122105020105700_CIT0116","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021122105020105700_CIT0117","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.2009-2464","article-title":"Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium","volume":"95","author":"Winer","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2021122105020105700_CIT0118","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.2007-2552","article-title":"Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism","volume":"93","author":"Winer","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2021122105020105700_CIT0119","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1210\/jc.2015-1855","article-title":"PTH(1-34) for surgical hypoparathyroidism: a prospective, open-label investigation of efficacy and quality of life","volume":"100","author":"Santonati","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021122105020105700_CIT0120","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1210\/jc.2017-01555","article-title":"PTH(1-34) for surgical hypoparathyroidism: a 2-year prospective, open-label investigation of efficacy and quality of life","volume":"103","author":"Palermo","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2021122105020105700_CIT0121","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1627","article-title":"Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure","volume":"27","author":"Gafni","year":"2012","journal-title":"J Bone Miner Res."},{"issue":"4","key":"2021122105020105700_CIT0122","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ecl.2018.07.013","article-title":"New directions in treatment of hypoparathyroidism","volume":"47","author":"Tabacco","year":"2018","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"11","key":"2021122105020105700_CIT0123","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","article-title":"Therapy of hypoparathyroidism with intact parathyroid hormone","volume":"21","author":"Rubin","year":"2010","journal-title":"Osteoporos Int."},{"issue":"4","key":"2021122105020105700_CIT0124","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"2021122105020105700_CIT0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12020-016-1141-0","article-title":"Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE Phase 3 Study","volume":"55","author":"Clarke","year":"2017","journal-title":"Endocrine."},{"issue":"5","key":"2021122105020105700_CIT0126","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4158\/EP15936.OR","article-title":"An open-label extension study of parathyroid hormone RHPTH(1-84) in adults with hypoparathyroidism","volume":"22","author":"Lakatos","year":"2016","journal-title":"Endocr Pract."},{"issue":"11","key":"2021122105020105700_CIT0127","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1210\/jc.2019-00893","article-title":"Therapy of hypoparathyroidism with rhPTH(1-84): a prospective, 8-year investigation of efficacy and safety","volume":"104","author":"Tay","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2021122105020105700_CIT0128","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1210\/jc.2019-01010","article-title":"Safety and efficacy of 5 years of treatment with recombinant human parathyroid hormone in adults with hypoparathyroidism","volume":"104","author":"Mannstadt","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2021122105020105700_CIT0129","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1210\/jc.2018-02430","article-title":"Quality of life in hypoparathyroidism improves with rhPTH(1-84) throughout 8 years of therapy","volume":"104","author":"Tabacco","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021122105020105700_CIT0130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1210\/jc.2009-2682","article-title":"Parathyroid hormone stimulates circulating osteogenic cells in hypoparathyroidism","volume":"96","author":"Rubin","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122105020105700_CIT0131","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/B978-0-12-397166-1.00057-6","article-title":"Treatment of hypoparathyroidism with parathyroid hormone.","volume-title":"The Parathyroids","author":"Vokes","year":"2015","edition":"3"},{"issue":"10","key":"2021122105020105700_CIT0132","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Sikjaer","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"5","key":"2021122105020105700_CIT0133","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00198-012-2230-4","article-title":"PTH replacement therapy of hypoparathyroidism","volume":"24","author":"Rejnmark","year":"2013","journal-title":"Osteoporos Int."},{"issue":"4","key":"2021122105020105700_CIT0134","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/jbmr.1493","article-title":"Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study","volume":"27","author":"Sikjaer","year":"2012","journal-title":"J Bone Miner Res."},{"issue":"11","key":"2021122105020105700_CIT0135","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/jbmr.3543","article-title":"The effects of long-term administration of rhPTH(1\u201384) in hypoparathyroidism by bone histomorphometry","volume":"33","author":"Rubin","year":"2018","journal-title":"J Bone Min Res."},{"issue":"7","key":"2021122105020105700_CIT0136","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/01926230601072301","article-title":"Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1-84 in a 2-year study in Fischer 344 rats","volume":"34","author":"Jolette","year":"2006","journal-title":"Toxicol Pathol."},{"issue":"3","key":"2021122105020105700_CIT0137","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","article-title":"Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety","volume":"30","author":"Vahle","year":"2002","journal-title":"Toxicol Pathol."},{"issue":"12","key":"2021122105020105700_CIT0138","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/jbmr.1800","article-title":"Safety of osteoanabolic therapy: a decade of experience","volume":"27","author":"Cipriani","year":"2012","journal-title":"J Bone Miner Res."},{"issue":"12","key":"2021122105020105700_CIT0139","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/jbmr.1768","article-title":"The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years","volume":"27","author":"Andrews","year":"2012","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2021122105020105700_CIT0140","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur J Endocrinol."},{"key":"2021122105020105700_CIT0141","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-18-0609","article-title":"Standards of care for hypoparathyroidism in adults: a Canadian and international consensus","volume":"180","author":"Khan","year":"2019","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2021122105020105700_CIT0142","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/bcp.13455","article-title":"Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and in hypoparathyroidism \u2013 translating the pharmacology","volume":"84","author":"Tay","year":"2018","journal-title":"Brit J Clin Pharmacol."},{"issue":"2","key":"2021122105020105700_CIT0143","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1530\/eje.1.01841","article-title":"Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone (PTH) secretory dynamics in human subjects","volume":"152","author":"Burattin","year":"2005","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2021122105020105700_CIT0144","first-page":"391","article-title":"Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","author":"Winer","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2021122105020105700_CIT0145","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/jbmr.3824","article-title":"Design and preclinical development of TransCon PTH, an investigational sustained-release PTH replacement therapy for hypoparathyroidism","volume":"34","author":"Holten-Andersen","year":"2019","journal-title":"J Bone Miner Res."},{"issue":"1","key":"2021122105020105700_CIT0146","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/jbmr.2917","article-title":"Prolonged pharmacokinetic and pharmacodynamic actions of a pegylated parathyroid hormone (1-34) peptide fragment","volume":"32","author":"Guo","year":"2017","journal-title":"J Bone Miner Res."},{"issue":"7","key":"2021122105020105700_CIT0147","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/jbmr.2811","article-title":"Pharmacodynamic actions of a long-acting PTH analog (LA-PTH) in thyroparathyroidectomized (TPTX) rats and normal monkeys","volume":"31","author":"Shimizu","year":"2016","journal-title":"J Bone Miner Res."},{"issue":"5","key":"2021122105020105700_CIT0148","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jbmr.2769","article-title":"Diphtheria toxin- and GFP-based mouse models of acquired hypoparathyroidism and treatment with a long-acting parathyroid hormone analog","volume":"31","author":"Bi","year":"2016","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2021122105020105700_CIT0149","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/bph.14028","article-title":"Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism","volume":"175","author":"Krishnan","year":"2018","journal-title":"Br J Pharmacol."},{"key":"2021122105020105700_CIT0150","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.1038\/ncomms13384","article-title":"Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism","volume":"7","author":"Tamura","year":"2016","journal-title":"Nat Commun."},{"issue":"9","key":"2021122105020105700_CIT0151","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/en.2015-1269","article-title":"The calcilytic agent NPS 2143 rectifies hypocalcemia in a mouse model with an activating calcium-sensing receptor (CaSR) mutation: relevance to autosomal dominant hypocalcemia type 1 (ADH1)","volume":"156","author":"Hannan","year":"2015","journal-title":"Endocrinology."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/6\/1722\/41829370\/jcem_105_6_1722.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/6\/1722\/41829370\/jcem_105_6_1722.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:03:59Z","timestamp":1640045039000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/6\/1722\/5823912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":151,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,4,22]]},"published-print":{"date-parts":[[2020,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa113","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6]]},"published":{"date-parts":[[2020,4,22]]}}}